Article info

Download PDFPDF
Randomised controlled trial
Initiating antiretroviral therapy in HIV-infected patients with >500 CD4 cells/µL provides more benefit than delaying treatment

Authors

  • George W Rutherford Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA; Department of Global Health Sciences, University of California, San Francisco, San Francisco, California, USA; PubMed articlesGoogle scholar articles
  • Andrew Anglemyer Department of Health, Human Services and Public Policy, California State University Monterey Bay, Seaside, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to : Professor George W Rutherford, Department of Global Health Sciences, University of California, San Francisco, Mission Hall, 550 16th Street, P.O. Box 1224, San Francisco, CA 94143-1224, USA; george.rutherford{at}ucsf.edu
View Full Text

Citation

Rutherford GW, Anglemyer A
Initiating antiretroviral therapy in HIV-infected patients with >500 CD4 cells/µL provides more benefit than delaying treatment

Publication history

  • First published December 11, 2015.
Online issue publication 
January 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.